Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Type 3 Von Willebrand International Registries Inhibitor Prospective Study

NCT02460458 is registered in ClinicalTrials.gov with Fondazione Angelo Bianchi Bonomi as lead sponsor.

NCT NCT02460458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02460458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Type 3 Von Willebrand International Registries Inhibitor Prospective Study
Lead sponsor
Fondazione Angelo Bianchi Bonomi
Phase
Observational
Overall status
Completed
Start date
November 5, 2012
Completion date
April 17, 2023
Enrollment
265 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

type 3 von willebrand's disease